Sign in

Hepatitis Monthly

Official Journal of Research Center for Gastroenterology and Liver Diseases

e-ISSN 1735-3408
p-ISSN 1735-143X
Authors GuideSubmit manuscript

Volume 4, Issue 7

19 articles2004-09-30Vol. 4Issue 7XML
30
Sep
2004
Optimal Therapy for Hepatitis C
Editorial

Optimal Therapy for Hepatitis C

Seyed AlavianORCID*
PDFFinal Published
30
Sep
2004
Acute Hepatitis C Infection
Review Article

Acute Hepatitis C Infection

Kamran LankaraniORCID*
PDFFinal Published
30
Sep
2004
Hepatitis C Infection with Persistently Normal ALT levels
Brief Report

Hepatitis C Infection with Persistently Normal ALT levels

Hamid Tavakoli,
Peyman Adibi*
PDFFinal Published
30
Sep
2004
Efficacy and Safety of Pegylated Interferon Alfa-2a plus Ribavirin for Treatment of Chronic Hepatitis C and Cirrhosis in Iranian
Research Article

Efficacy and Safety of Pegylated Interferon Alfa-2a plus Ribavirin for Treatment of Chronic Hepatitis C and Cirrhosis in Iranian

Seyed Alavian*,
Behzad Hajarizadeh,
Bashir Hajibeigi,
Taher Doroudi,
Amir Hamadanizadeh,
Koroush Abar
PDFFinal Published
30
Sep
2004
Peginterferon alfa-2a and Ribavirin in Patients with Chronic Hepatitis C and Inherited Bleeding Disorders
Research Article

Peginterferon alfa-2a and Ribavirin in Patients with Chronic Hepatitis C and Inherited Bleeding Disorders

Shahin Merat,
Amir Sohrabpour,
Siamak Khaleghi,
Masoud Sohrabi,
Katayon Rad,
Amir Radmard
,et al.
PDFFinal Published
30
Sep
2004
The Efficacy and Safety of Peginterferon Alpha-2a (PEGASYS) monotherapy in the Treatment of Chronic Hepatitis C Infected Subjects with Transfusion Dependent Thalassemia
Research Article

The Efficacy and Safety of Peginterferon Alpha-2a (PEGASYS) monotherapy in the Treatment of Chronic Hepatitis C Infected Subjects with Transfusion Dependent Thalassemia

Shahram Mirmomen*,
Naser Daryani,
Reza Malekzadeh,
Mohammad Zali,
Babak Haghpanah,
Parisa Poursamimi
,et al.
PDFFinal Published
30
Sep
2004
The Efficacy and Side Effects of Therapy with Peginterferon Alpha-2 a (PEGASYS) Combined with Ribavirin in Chronic Hepatitis C Patients: an open label Clinical Trial
Research Article

The Efficacy and Side Effects of Therapy with Peginterferon Alpha-2 a (PEGASYS) Combined with Ribavirin in Chronic Hepatitis C Patients: an open label Clinical Trial

Nasser Daryani*,
Babak Haghpanah,
Ali Sayyah,
Ali Hashtroudi,
Mohammad Bashashati,
Parisa Poursamimi
,et al.
PDFFinal Published
30
Sep
2004
Peginterferon Alfa-2a (Pegasys) and Ribavirin in the Treatment of Chronic Hepatitis C
Research Article

Peginterferon Alfa-2a (Pegasys) and Ribavirin in the Treatment of Chronic Hepatitis C

Mohammad Zali*,
Hamid Shalmani,
Mohsen Norouzinia,
Amir MohammadAlizadeh,
Azita Nowroozi,
Negar Behrouz
PDFFinal Published
30
Sep
2004
Hearing Loss as a Complication of Peginterferon Alfa 2a Combination Therapy in a Patient with Hepatitis C Virus Infection
Case Report

Hearing Loss as a Complication of Peginterferon Alfa 2a Combination Therapy in a Patient with Hepatitis C Virus Infection

Mohssen Toosi*,
Mohammad Hassanabadi
PDFFinal Published
30
Sep
2004
Amantadine therapy for chronic hepatitis C: a dose escalation study
Letter

Amantadine therapy for chronic hepatitis C: a dose escalation study

Smith JP,
Riley 3rd,
Bingaman S,
Mauger DT,
Shahram Mirmomen*
PDFFinal Published
30
Sep
2004
A multicentre study of the usefulness of liuer biopsy in hepatitis [ J Uiral Hep 2004 July; 11 (4): 375
Letter

A multicentre study of the usefulness of liuer biopsy in hepatitis [ J Uiral Hep 2004 July; 11 (4): 375

Seyed AlavianORCID*,
Sbahram Mirmomen,
V:G:Bain ,
M Bonacini,
S Govindarajan,
M Ma
,et al.
PDFFinal Published
30
Sep
2004
ABSTRACTED ARTICLES (IRAN)
Meeting Report

ABSTRACTED ARTICLES (IRAN)

PDFFinal Published
30
Sep
2004
ABSTRACT ARTICLE (MIDDLE EAST COUNTRIES)
Meeting Report

ABSTRACT ARTICLE (MIDDLE EAST COUNTRIES)

PDFFinal Published
30
Sep
2004
ABSTRACT ARTICLE(TREATMENT)
Meeting Report

ABSTRACT ARTICLE(TREATMENT)

PDFFinal Published
30
Sep
2004
ABSTRACT ARTICLE (DIAGNOSIS)
Meeting Report

ABSTRACT ARTICLE (DIAGNOSIS)

PDFFinal Published
30
Sep
2004
ABSTRACT ARTICLE(EPIDEMIOLOGY)
Meeting Report

ABSTRACT ARTICLE(EPIDEMIOLOGY)

PDFFinal Published
30
Sep
2004
ABSTRACT ARTICLE(COMPLICATION)
Meeting Report

ABSTRACT ARTICLE(COMPLICATION)

PDFFinal Published
30
Sep
2004
ABSTRAC ARTICLE(PATHOGENESIS)
Meeting Report

ABSTRAC ARTICLE(PATHOGENESIS)

PDFFinal Published
30
Sep
2004
ABSTRACT ARTICLE(OTHER)
Meeting Report

ABSTRACT ARTICLE(OTHER)

PDFFinal Published